Clover Health Investments, Corp. - Class A Common stock (CLOV)
4.3800
+0.0600 (1.39%)
Clover Health Investments Corp is a healthcare technology company focused on improving the health outcomes of Medicare beneficiaries
By utilizing its proprietary data-driven platform, Clover Health aims to enhance care delivery and streamline operations for its members, promoting preventive care and tailored health services. The company partners with healthcare providers to deliver more efficient and personalized care, ultimately seeking to reduce costs and improve patient satisfaction in the healthcare system. Through innovation and technology, Clover Health strives to make healthcare more accessible and effective for seniors across the United States.
Previous Close | 4.320 |
---|---|
Open | 4.360 |
Bid | 4.350 |
Ask | 4.390 |
Day's Range | 4.330 - 4.440 |
52 Week Range | 0.6060 - 4.870 |
Volume | 3,221,412 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 6,969,155 |
News & Press Releases
![](https://cdn.benzinga.com/files/images/story/2025/01/22/amd-shutter3.jpeg?width=1200&height=800&fit=crop)
Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in.
Via Benzinga · January 22, 2025
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 10, 2024
Here are a variety of lesser-known charts from my “Recents” watch list. Quite a few of them look like good bullish plays.
Via Talk Markets · November 30, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/09/Medicaid-Healthcare.jpeg?width=1200&height=800&fit=crop)
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.
Via Benzinga · November 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 25, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 3, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 9, 2024
![](https://www.financialnewsmedia.com/wp-content/uploads/2024/11/AVAI-banner-1119.jpg)
EQNX::TICKER_START (OTCQB:AVAI),(NYSETDOC),NASDAQ:TEMNASDAQTEM)(NYSE:MDTNYSEMDT,(NASDAQ:CLOVNASDAQ) EQNX::TICKER_END
Via FinancialNewsMedia · November 20, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 7, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 7, 2024
![](https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png)
PALM BEACH, Fla. , Nov. 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Healthcare Artificial Intelligence (AI) market exhibits a high degree of innovation, characterized by ongoing advancements in technology. Rapid developments in ML, deep learning, NLP, and computer vision are driving the evolution of AI-powered healthcare solutions. One primary factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes. According to a March 2024 Microsoft-IDC study, 79% of healthcare organizations are presently utilizing AI technology. In addition, the return on investment (ROI) is realized within 14 months, generating USD 3.20 for every USD 1 invested in artificial intelligence (AI). AI technologies hold transformative potential in various areas including medical imaging analysis, predictive analytics, personalized treatment planning, and drug discovery, potentially transforming conventional healthcare practices. A report from Grand View Research said the global AI in healthcare market size, which was estimated at USD 19.27 billion in 2023, is expected to grow at a CAGR of 38.5% from 2024 to 2030. The report said: “Mergers & acquisitions (M&As) play a significant role in shaping the healthcare AI market landscape. Companies [that] engage in M&A activities to expand their AI software and services increase their market reach or acquire specialized technology and expertise. End-users are becoming increasingly aware of the potential benefits of AI in improving patient care, operational efficiency, and healthcare outcomes. Education initiatives and industry events helped raise awareness about the capabilities and applications of AI in healthcare.” A.I. companies active in the markets include: Avant Technologies Inc. (OTCQB: AVAI), Teladoc Health, Inc. (NYSETDOC), Tempus AI, Inc. NASDAQ: TEMNASDAQTEM)(NYSE: MDTNYSEMDT, Clover Health Investments, Corp. (NASDAQ: CLOVNASDAQ).
By FN Media Group LLC · Via GlobeNewswire · November 20, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/17/abbvie-shutter.jpeg?width=1200&height=800&fit=crop)
AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.
Via Benzinga · October 17, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/11/doctor-2568481.jpeg?width=1200&height=800&fit=crop)
Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025.
Via Benzinga · October 11, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/02/Trump-Media--Technology--GameStop--Aliba.jpeg?width=1200&height=800&fit=crop)
U.S. indices closed Wednesday in positive territory, with the Dow Jones Industrial Average increasing by 0.09% to 42,196.52.
Via Benzinga · October 2, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/02/untitled_4.jpeg?width=1200&height=800&fit=crop)
Clover Health Investments shares are trading higher Wednesday amid increased trading volume and gaining traction across social media platforms. Here's what you need to know.
Via Benzinga · October 2, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 2, 2024
![](/next-assets/images/schema-image-default.png)
Via Benzinga · October 2, 2024
![](https://g.foolcdn.com/editorial/images/789243/a-person-looking-at-a-chart-on-their-laptop.jpg)
Short reports can be crippling for a stock in the short term, but what about the longer run?
Via The Motley Fool · September 10, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/04/earnings.jpeg?width=1200&height=800&fit=crop)
Clover Health stock is moving higher Wednesday after the company's subsidiary, Counterpart Health, announced a multi-year agreement with Iowa Clinic.
Via Benzinga · September 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/04/xrdDAFlCWD77dU2-j2660894045622293926-t23.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/03/untitled_1.jpeg?width=1200&height=800&fit=crop)
Clover Health Investments Corp shares are trading higher in extended trading Tuesday after one of the company's subsidiaries announced a multi-year agreement with The Iowa Clinic.
Via Benzinga · September 3, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/28/pvh-calvin-klein-shutterstock-753006271.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 28, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/22/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 22, 2024